1
Return

Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes

delete2025-11-14
delete0
delete
OA
AI
C
Carol J. Levy *
L
Lauren Kanapka
S
Sue A. Brown
S
Sheryl Marks
T
Tamara Spaic
D
Devin Steenkamp
V
Virginia S. Lu
P
Peter Zhao
J
John W. Lum
R
Roy W. Beck
J
Jordan E. Pinsker
DOI:10.1177/15209156251395035delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Objective: To characterize simplified meal bolus strategies in adults with insulin-treated type 2 diabetes using automated insulin delivery (AID). Research Design and Methods: In the 2IQP study, a 13-week randomized, controlled trial comparing Control-IQ+ AID to continuation of pre-study insulin regimen with continuous glucose monitoring, 201 participants in the AID arm were classified by meal bolus strategy. Glycemic outcomes were compared to baseline. Results: 68 participants’ meal bolus strategies (33.8%) were classified as Carbohydrate Counting, 79 (39.3%) were classified as Preset Carbohydrate Amounts, 27 (13.4%) were classified as Fixed Insulin Doses, and 27 (13.4%) as Other Methods. All bolus strategies were associated with similar, significant improvements in HbA1c from baseline: −0.9% for Carbohydrate Counting (P < 0.001), −1.1% for Preset Carbohydrate Amounts (P < 0.001), −0.8% for Fixed Insulin Doses (P < 0.001), and −0.9% for Other Methods (P = 0.003). Hypoglycemia rates were low at baseline and remained low for all bolus strategies. As participants gained experience with the Control-IQ+ AID system, more participants opted to use a simplified bolus strategy in the second half of the study compared with the first half (63% vs. 52%). Conclusion: Simplified bolus strategies worked well for adults with type 2 diabetes using Control-IQ+ in the 2IQP trial. All bolus strategies led to substantial HbA1c improvements, without safety concerns.
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Diabetes Technology and Therapeutics cover
Diabetes Technology and Therapeutics
IF:
6.3
Papers:
2.9K
Citations:
7.5K

Organization

No organization information available
Cited Papers

Cited Papers

Citing Papers

Citing Papers